Buy or sell Click Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Click Therapeutics Stock

Click Therapeutics engineers, validates, and commercializes Digital Therapeutics™ applications

About Click Therapeutics Stock

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

Funding History

April 2012$200K
October 2014$1.7M
August 2015$1.8M
April 2016$950K
April 2017$3.7M
October 2018$19.0M


Chief Financial Officer

Ted Silver

Founder & CIO

Victor Gao

Founder & CEO

David Benshoof Klein

Chief Technology Officer

Christopher Jordan

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Click Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: